Ginkgo Bioworks Holdings Inc (DNA) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 3.50%20.16 | 19.47 | 33.40 | 38.84 | 49.60 |
| Cost Of Revenue | 44.51%1.72 | 3.10 | - | - | - |
7.43%46.21 | 49.92 | - | - | - | |
| Research and Development | 7.43%46.21 | 49.92 | - | - | - |
| Costs And Expenses | 13.37%78.70 | 90.85 | 114.79 | 119.59 | 110.19 |
| Depreciation and Amortization | 3.78%12.32 | 12.80 | 13.66 | 14.17 | 15.79 |
| Operating Income/Loss | 17.97%-58.55 | -71.37 | -70.75 | -90.02 | -65.54 |
| Net Interest Income/Expense | 10.12%3.23 | 3.60 | - | 5.74 | 6.08 |
| Income/Loss From Equity Method Investments | -4.67 | - | - | - | - |
| Income/Loss From Continuing Operations Before Tax | 24.88%-57.19 | -76.14 | -81.39 | -80.75 | -60.58 |
| Income Tax Expense/Benefit | 260.00%0.13 | -0.08 | -0.64 | 0.00 | -0.28 |
| Income/Loss From Continuing Operations After Tax | 24.64%-57.32 | -76.06 | -80.75 | -80.76 | -60.30 |
| Income/Loss From Discontinued Operations, Net Of Tax | 262.55%10.61 | -6.53 | - | - | - |
43.44%-46.71 | -82.59 | -80.75 | -80.76 | -60.30 | |
| Attributable To Parent | 43.44%-46.71 | -82.59 | -80.75 | -80.76 | -60.30 |
| Basic Average Shares | 4.25%62.09 | 59.56 | 0.54 | 55.63 | 54.86 |
| Basic Earnings Per Share | 46.04%-0.75 | -1.39 | -1.42 | -1.45 | -1.10 |